In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients’ quality of life.Le texte complet de cet article est disponible en PDF.
Key words : chemoprophylaxis, disease burden, disease relapse, drug resistance, Hansen's disease, immunoprophylaxis, leprosy, leprosy treatment, Lucio phenomenon, National Hansen's Disease Program, prevention, type 1 leprosy reaction, type 2 leprosy reaction
Abbreviations used : BB, BCG, BL, BT, ENL, LL, MB, NHDP, PB, T1R, T2R, TT, WHO
| Funding sources: None.
| Conflicts of interest: None disclosed.
| Date of release: July 2020.
| Expiration date: July 2023.